Blog

Integra LifeSciences (IART) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.63 per share a year ago

Proto Labs (PRLB) came out with quarterly earnings of $0.41 per share, beating the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.38 per share a year ago. These figures

City Office REIT (CIO) came out with quarterly funds from operations (FFO) of $0.28 per share, in line with the Zacks Consensus Estimate . This compares to FFO of $0.28 per share a year ago. These

KBR Inc. (KBR) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.88 per share. This compares to earnings of $0.83 per share a year ago. These figures

Cigna (CI) came out with quarterly earnings of $7.2 per share, beating the Zacks Consensus Estimate of $7.14 per share. This compares to earnings of $6.72 per share a year ago. These figures are

Amadeus IT Group SA Unsponsored ADR (AMADY) came out with quarterly earnings of $0.95 per share, missing the Zacks Consensus Estimate of $0.96 per share. This compares to earnings of $0.89 per share

If you have been looking for Allocation Balanced funds, a place to start could be Franklin Income Advisor (FRIAX). FRIAX carries a Zacks Mutual Fund Rank of 2 (Buy), which is based on various

On the lookout for a Sector - Health fund? Starting with Fidelity Advisor Biotechnology A (FBTAX) is one possibility. FBTAX bears a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on

If investors are looking at the Large Cap Growth fund category, make sure to pass over Fidelity Focused Stock Fund (FTQGX). FTQGX bears a Zacks Mutual Fund Rank of 4 (Sell), which is based on

There are plenty of choices in the Non US - Equity category, but where should you start your research? Well, one fund that might be worth investigating is American Funds New World A (NEWFX). NEWFX

On the lookout for a Allocation Balanced fund? Starting with Fidelity Asset Manager 50% (FASMX) should not be a possibility at this time. FASMX has a Zacks Mutual Fund Rank of 4 (Sell), which is

Economic growth in the Eurozone outperformed expectations in the last quarter, despite global trade uncertainties. This resilience may lessen the need for additional interest rate cuts by the

The Strive 500 ETF (STRV) was launched on September 15, 2022, and is a passively managed exchange traded fund designed to offer broad exposure to the Large Cap Blend segment of the US equity market.

The Invesco Water Resources ETF (PHO) was launched on 12/06/2005, and is a smart beta exchange traded fund designed to offer broad

Looking for broad exposure to the Small Cap Blend segment of the US equity market? You should consider the Global X Russell 2000 ETF (RSSL), a passively managed exchange traded fund launched on June

Launched on September 23, 2015, the FlexShares US Quality Large Cap ETF (QLC) is a passively managed exchange traded fund designed to provide a broad exposure to the Large Cap Blend segment of the

If you're interested in broad exposure to the Large Cap Value segment of the US equity market, look no further than the Invesco Dividend Achievers ETF (PFM), a passively managed exchange traded fund

The First Trust Materials AlphaDEX ETF (FXZ) was launched on 05/08/2007, and is a smart beta exchange traded fund designed to offer broad

Making its debut on 11/15/2007, smart beta exchange traded fund Invesco Fundamental High Yield Corporate Bond ETF (PHB) provides

Looking for broad exposure to the Small Cap Blend segment of the US equity market? You should consider the iShares U.S. Small-Cap Equity Factor ETF (SMLF), a passively managed exchange traded fund

Making its debut on 08/27/2007, smart beta exchange traded fund First Trust STOXX European Select Dividend ETF (FDD) provides investors

A smart beta exchange traded fund, the SPDR S&P Insurance ETF (KIE) debuted on 11/08/2005, and offers broad exposure to the

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

MongoDB, Inc. MDB: This provider of a database platform has seen the Zacks Consensus Estimate for its current year earnings

After a surprise contraction in the first quarter, the U.S. economy rebounded strongly in the second quarter of 2025. According to the advance estimate of the Bureau of Economic Analysis (BEA)

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

Creative Medical Technology Holdings, Inc. CELZ is a commercial-stage biotechnology company. The Zacks Consensus Estimate